A detailed history of Berkeley Capital Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Berkeley Capital Partners, LLC holds 1,308 shares of LLY stock, worth $1 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
1,308
Previous 1,209 8.19%
Holding current value
$1 Million
Previous $1.09 Million 5.85%
% of portfolio
0.33%
Previous 0.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $76,441 - $95,041
99 Added 8.19%
1,308 $1.16 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $95,682 - $119,993
132 Added 12.26%
1,209 $1.09 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $123,177 - $164,794
208 Added 23.94%
1,077 $837,000
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $129,721 - $152,925
247 Added 39.71%
869 $506,000
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $270,383 - $372,764
622 New
622 $334,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Berkeley Capital Partners, LLC Portfolio

Follow Berkeley Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley Capital Partners, LLC with notifications on news.